Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–57.

Article  PubMed  PubMed Central  Google Scholar 

Fitzwater SP, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2012;31(5):501–8.

Article  PubMed  Google Scholar 

Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-999.

Article  PubMed  Google Scholar 

Van Dyke M, Pirçon JY, Cohen R, Madhi S, Rosenblüt A, Parra MM, et al. Etiology of acute otitis media in children less than 5 years of age: a pooled analysis of 10 similarly designed observational studies. Pediatr Infect Dis J. 2017;36(3):274–81.

Article  PubMed  Google Scholar 

Bruyn GAW, van Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis. 1991;10:897–910.

Article  CAS  PubMed  Google Scholar 

Global Pneumococcal Sequencing Project. Serotypes. 2022. Available from: https://www.pneumogen.net/gps/serotypes.html. Accessed 02 Mar 2023.

Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30(1):100–21.

Article  CAS  PubMed  Google Scholar 

Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson LG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190(7):1203–11.

Article  PubMed  Google Scholar 

Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci. 2013;28(1):4–15.

Article  PubMed  PubMed Central  Google Scholar 

Lister S. The use of pneumococcal vaccine. South Afr Med Record. 1924;22(6):115–22.

Google Scholar 

Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis. PLoS One. 2017;12(1): e0169368.

Article  PubMed  PubMed Central  Google Scholar 

Westerink MAJ, Schroeder HW, Nahm MH. Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination. Aging Dis. 2011;3(1):51–67.

PubMed  PubMed Central  Google Scholar 

CDC. Pneumococcal Vaccination: What Everyone Should Know. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/public/index.html. Accessed 27 Feb 2023.

EMA. Apexxnar. 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/apexxnar. Accessed 27 Feb 2023.

EMA. Vaxneuvance. 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/vaxneuvance. Accessed 27 Feb 2023.

WHO. Pneumococcal vaccines WHO position paper – 2012 – recommendations. Vaccine. 2012;30(32):4717–8.

Article  Google Scholar 

JHSPH. VIEW-hub Report: Global Vaccine Introduction and Implementation. 2021. Available from: https://www.jhsph.edu/ivac/wp-content/uploads/2021/05/VIEW-hubReport_March2021.pdf. Accessed 27 Feb 2023.

WHO. World Health Organisation. 2022. Available from: https://immunizationdata.who.int/pages/coverage/pcv.html?CODE=SEAR&ANTIGEN=&YEAR=XS. Accessed 27 Feb 2023.

Kirolos A, Blacow RM, Parajuli A, Welton NJ, Khanna A, Allen SJ, et al. The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis. BMJ Global Health. 2021;6(11):7411.

Article  Google Scholar 

National Institute of Health. National health and morbidity survey 2019: NCD. 2020. Available from: https://iku.gov.my/nhms. Accessed 18 Feb 2023.

Department of Statistics Malaysia. Statistics on Causes of Death, Malaysia, 2022. 2022. Available from: https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=401&bul_id=QkxLckg3WjlzcEZyVzRIajllenBIQT09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09. Accessed 18 Feb 2023.

Ooi JM, Eg KP, Chinna K, Nathan AM, de Bruyne JA, Thavagnanam S. Predictive risk factors for complicated pneumonia in Malaysian children. J Paediatr Child Health. 2019;55(4):406–10.

Article  PubMed  Google Scholar 

MyHealth Malaysia. The Malaysian National Immunisation Programme (NIP). 2021. Available from: https://immunise4life.my/the-malaysian-national-immunisation-programme-nip/. Accessed 18 Feb 2023.

GAVI.org. Eligibility. 2020. Available from: https://www.gavi.org/types-support/sustainability/eligibility. Accessed 18 Feb 2023.

Aljunid S, Abuduxike G, Ahmed Z, Sulong S, Muhd Nur A, Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infect Dis. 2011;11:248.

Article  PubMed  PubMed Central  Google Scholar 

Le CF, Jefferies JM, Yusof MYM, Sekaran SD, Clarke SC. The epidemiology of pneumococcal carriage and infections in Malaysia. Expert Rev Anti Infect Ther. 2012;10(6):707–19.

Article  CAS  PubMed  Google Scholar 

Su-Lyn B. What happened to Malaysia’s pneumococcal vaccination programme?. CodeBlue. Available from: https://codeblue.galencentre.org/2020/07/10/what-happened-to-malaysias-pneumococcal-vaccination-programme/. Accessed 20 Jul 2023.

Mypositiveparenting. About positive parenting. 2018. Available from: https://mypositiveparenting.org/about-us/. Accessed 18 Feb 2023.

Malaysian Paediatric Association. YES to Pneumococcal Protection. Kuala Lumpur: Persatuan Pediatrik Malaysia; 2013.

Google Scholar 

Harapan P. Buku harapan: Rebuilding our nation, fulfilling our hopes. 2018. Available from: https://kempen.s3.amazonaws.com/manifesto/Manifesto_text/Manifesto_PH_EN.pdf. Accessed 17 Jul 2023.

Ministry of Finance Malaysia. Budget 2020. 2020. Available from https://phl.hasil.gov.my/pdf/pdfam/Budget_2020.pdf. Accessed 17 July 2023.

Musa H. All you need to know about the pneumococcal vaccine in the NIP. 2021. Available from: https://mypositiveparenting.org/2021/08/06/all-you-need-to-know-about-the-pneumococcal-vaccine-in-the-nip/. Accessed 18 Feb 2023.

Shafie AA, Ahmad N, Naidoo J, Yoong Foo C, Wong C, Pugh S, Tan KK. Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia-an economic evaluation. Hum Vaccin Immunother. 2020;16(7):1719–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ministry of Health Malaysia. Health technology assessment: childhood immunisation. Kuala Lumpur: HealthTechnology Assessment Unit; 2001.

Google Scholar 

gov.my. Second Meeting, Fourth Term, Fourteenth Parliament December 2021. gov.my; 2021. Available from: https://www.parlimen.gov.my/files/jindex/pdf/JDR14122021.pdf. Accessed 19 Feb 2023.

Azizi FSM, Kew Y, Moy FM. Vaccine hesitancy among parents in a multi-ethnic country, Malaysia. Vaccine. 2017;35(22):2955–61.

Article  Google Scholar 

Department of Statistics Malaysia. Household income and basic amenities survey report. Putrajaya: Jabatan Perangkaan Malaysia; 2019.

Google Scholar 

Ja’afar S. Vaccination program: governance and policy decision process in Malaysia. 2016. Available from: https://www.fondation-merieux.org/wp-content/uploads/2017/02/estimating-the-full-public-health-value-of-vaccines-2016-safurah-jaafar.pdf. Accessed 19 Feb 2023.

Zulkifili A, Azehar NS, Zamalolaily SN, Zulfaka ZR, Hamid SA. Perception on pneumococcal vaccination towards infants among the community in Selayang, Selangor: a qualitative study. Asian J Med Health Sci. 2022;5(2):134–44.

Google Scholar 

Ministry of Health Malaysia. Ministry of Health Malaysia. 2014. Available from: https://www.moh.gov.my/moh/resources/auto%20download%20images/587f11568fcaa.pdf. Accessed 19 Feb 2023.

Tricarico S, McNeil HC, Head MG, Cleary DW, Clarke SC. Informing pneumococcal conjugate vaccine policy in middle income countries: the case of Malaysia. Vaccine. 2017;18(35):2288–90.

Article  Google Scholar 

MSIDC. Available Vaccines - Pneumococcal. 2023. Available from: https://adultimmunisation.msidc.my/pneumococcal/. Accessed 19 Feb 2023.

Ministry of Health Malaysia. Pneumococcal vaccination with 23-valent pneumococcal polysaccharide vaccine (PPV23) for elderly. 2020 Available from: https://www.moh.gov.my/index.php/database_stores/attach_download/347/370. Accessed 19 Feb 2023.

Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia (Nathan). 2021;13(1):9. https://doi.org/10.1186/s41479-021-00086-7.

Article  PubMed  PubMed Central  Google Scholar 

Rodgers GL, Klugman KP. Surveillance of the impact of pneumococcal conjugate vaccines in developing countries. Hum Vaccin Immunther. 2016;12(2):417–20.

Article  Google Scholar 

Lo S, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis. 2019;19(7):759–69.

Article  PubMed  PubMed Central  Google Scholar 

Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, et al. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 2015;28(3):871–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lo SW, Mellor K, Cohen R, Alonso AR, Belman S, Kumar N, et al. Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study. Lancet Microbe. 2022;3(10):e735–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ministry of Health Malaysia. Malaysian Action Plan on Antimicrobial Resistance (MyAP-AMR) 2017–2021. 2018. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Garis%20Panduan/Garis%20panduan%20Umum%20(Awam)/National_Action_Plan_-_FINAL_29_june.pdf. Accessed 19 Feb 2023.

Morris DE, McNeil H, Hocknell RE, Anderson R, Tuck AC, Tricarico S, et al. Carriage of upper respiratory tract pathogens in rural communities of Sarawak, Malaysian Borneo. Pneumonia. 2021;13:6.

Article  PubMed  PubMed Central  Google Scholar 

Rahman NA, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16(1):208.

Article  Google Scholar 

Dzaraly ND, Desa MNM, Muthanna A, Masri SN, Taib NM, Suhaili Z, et al. Antimicrobial susceptibility, serotype distribution, virulence profile and molecular typing of piliated clinical isolates of pneumococci from east coast, Peninsular Malaysia. Sci Rep. 2021;11:8220.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu E, Chen HH, Zhao H, Ozawa S. Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobi